Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ICE2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
INPP5A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAP4K5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC25A42 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
L2HGDH - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ESYT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
VKORC1L1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C11orf58 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZWILCH - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SCAMP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CCNDBP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CDK8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DLG3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FBXO22 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ATG5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
STRBP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM219B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NANS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on